Penny stocks are incredibly dangerous investments that can burn new and seasoned investors alike. InvestorPlace’s best micro-cap analysts recommend buying penny stocks, or cheap stocks, only with the strictest of warnings. But while pink sheet stocks can be halved in the blink of an eye, they can also double much quicker than large-cap stocks.
Penny Stocks
Sundial Growers May Rebound, but It’s Likely to Fall a Lot Further First
Yet, with the high chances shares fall back to 60 cents per share, it's not worth buying in today. If you want to take a gamble with SNDL stock, take your time. Wait for the markets to fully absorb its past and upcoming dilution.
Genius Brands Is Still Speculative Despite a Big ‘Discount’
Genius Brands dipped badly on company announcements that didn’t hit the mark, but could this be a buying opportunity for GNUS stock?
Do Not Bet on Zomedica… At Least Not Yet
The early launch of Zomedica's Truforma does not guarantee commercial success. Before you bet on ZOM stock, the company needs to prove itself.
Analyze Senseonics Thoroughly Before You Feed the Meme
SENS stock is banking on an FDA approval for its diabetes sensor. However, you’ll want to analyze the fundamentals before proceeding.
For a Speculative Trade in Education Abroad, Try ATA Creativity Global
If you're going to own AACG stock, you'd better be prepared for massive price moves - but if your timing is good, the returns could be huge.
Mark a Major Medical Milestone with Check-Cap
Why should you check out CHEK stock? An FDA approval, along with an impressive year-end capital position, provide a solid case for Check-Cap.
Denison Mines Reminds You to Keep Your Eyes Up Here
With uranium being the most energy-dense commodity, the fundamental narrative for DNN stock is an incredibly positive one.
Should You Buy Into Northern Dynasty Minerals’ $2-Billion Dream?
Northern Dynasty Minerals got a boost when the U.S. Army Corps of Engineers accepted its appeal request. Now, NAK stock is still in the game.
Be Cautious as Onconova Therapeutics Stock Flirts With De-Listing
Onconova's targeted anti-cancer agents enhance the bull thesis for ONTX stock, but the stock's volatile price action raises a red flag.
Is Genius Brands Going to Ride Shaq to $10 and Beyond?
Genius Brands has made high-profile announcements in recent weeks that lit a fire under GNUS stock. Will it now go to the next level?
Tomslist: The 5 Top Penny Stock Stories of the Week: OCG, SPRT, DLPN, ZOM, SNDL
Even the top penny stocks have their dog days. Here's a celebration of this week's weirdest plays: OCT, SPRT, DLPN, ZOM and SNDL.
Numinus Wellness May Be the Best Penny Stock to Buy Today
Penny stocks are never great bets, but LKYSF stock may be an important exception to that rule, given its huge potential in the Shroom Boom.
Wait for Acasti Pharma Stock to Fall Further Before Buying
The future course of ACST stock depends largely on the company's lead drug candidate, CaPre. Any good news could send the shares higher.
Sundial Growers Is a Heavy Lift for Retail Investors
Sundial Growers is not drawing much interest from institutional investors. That leaves SNDL stock with little reward for investors' efforts.
Transenterix Stock Has More Problems Than a Simple Name Change Can Fix
TRXC stock has undergone a name change but that doesn’t change the nature of the investment, for better or for worse.
